supported by grants from the National Natural Science Foundation of China(Nos.82070776,81900370,81970655,82270796,and 82200849);the Science and Technology Innovation Program of Hunan Province(No.2022RC3071);the Natural Science Foundation of Hunan Province(Nos.2021JJ30946 and 2022JJ30808)
Background:Homoharringtonine(HHT)is an effective anti-inflammatory,anti-viral,and anti-tumor protein synthesis inhibitor that has been applied clinically.Here,we explored the therapeutic effects of HHT in a mouse hear...
supported by the National Natural Science Foundation of China(81670137);Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support(20152501);State Key Laboratory of Medical Genomics Support(201802);Jiading District Health Commission Chinese Medicine Youth Research Support(2019-QN-ZYY-03).
Understanding the molecular pathogenesis of acute myeloid leukemia(AML)with well-defined genomic abnormalities has facilitated the development of targeted therapeutics.Patients with t(8;21)AML frequently harbor a fusi...
Supported by the Science and Technology Planning Project of Health Commission of Jiangxi Province(SKJP220229261).
[Objectives]To explore the effects of homoharringtonine(HHT)on the proliferation and apoptosis of melanoma cells.[Methods]Mouse melanoma cell line B16F10 was divided into 5 dfferent dose groups,among which Oμg/mL HHT...
The authors would like to appreciate the funding of National Key Research and Development Program of China(2019YFC0840605).
Introduction:Acute promyelocytic leukemia(APL)is mostly due to the chromosome translocation t(15;17)(q22;q12),leading to the formation of PML-RARA fusion protein.Some patients carried rare translocation involving RARA...
the National Natural Science Foundation of China (No.81270623);the Science and Technology Commission of Shanghai Municipality (No.14411950600);the Public Health 3-Year Project of Shanghai Children's Medical Center(No.GWIV-25).
Homoharringtonine (HHT),a plant alkaloid from Cephalotaxus harringtonia,exhibits a unique anticancer mechanism and has been widely used in China to treat patients with acute myeloid leukemia (AML) since the 1970s.Tria...
Collaboration of c-KIT mutations with AML1-ETO (AE) has been demonstrated to induce t(8;21) acute myeloid leukemia (AML).Targeted therapies designed to eliminate AE and c-KIT oncoproteins may facilitate effective trea...
National Natural Science Foundation of China(81270621,81300451);National Public Health Grand Research Foundation(201202003);Shanghai Health System Advanced and Appropriate Technology Promotion Projects(2013SY001);Multiple Clinical Research Center Program of Shanghai Jiao Tong University School of Medicine(DLY201513)
Objective · To compare the efficacy and prognostic factors of HCAG regimen with traditional IA regimen in the treatment of newly diagnosed elderly acute myeloid leukemia(AML) patients. Methods · Forty-one patients w...
Objective To compare the efficacy and toxicities of combining homoharringtonine(HHT)±daunorubicin(DNR)with all-transretinoic acid(ATRA)based therapy and DNR plus ATRA based therapy in newly diagnosed low/intermediate...
In the present study, we aimed to assess the efficacy and safety of Homoharringtonine (HHT) for chronic myelogenous leukemia (CML). Databases, such as PubMed, the Cochrane Library, EMbase, CENTRAL, VIP, WanFang Da...